FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Torrent Pharma Anagrelide Capsules Recall

Anagrelide Capsules, USP, 0

Torrent Pharma Inc. · Basking Ridge, NJ

Risk level
Class II
Reported by FDA
Sep 25, 2019
Recall ID
D-1862-2019
Check your lot numberHow we source this data

Summary

Torrent Pharma recalled Anagrelide Capsules starting Sep 6, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1862-2019 on Sep 25, 2019. Reason: Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.

Product description

Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-453-01.

Lot numbers, UPCs & expiration codes

Lot #: BFE2E003, Exp 08/31/2020

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1862-2019
Classification
Class II
Status
Terminated
Recall initiated
Sep 6, 2019
FDA report date
Sep 25, 2019
Quantity
2472 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Torrent Pharma Inc.

Original FDA data

Every field from FDA enforcement report D-1862-2019, exactly as published.

Show all FDA fields
City
Basking Ridge
State
NJ
Status
Terminated
Country
United States
Event ID
83733
Address
150 Allen Rd Ste 102
Code information
Lot #: BFE2E003, Exp 08/31/2020
Postal code
07920-3856
Report date
Sep 25, 2019
Product type
Drugs
Recall number
D-1862-2019
Classification
Class II
Recalling firm
Torrent Pharma Inc.
Product quantity
2472 bottles
Termination date
Nov 3, 2020
Reason for recall
Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-453-01.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Sep 6, 2019
Initial firm notification
Letter
Center classification date
Sep 16, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1862-2019, published Sep 25, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls